The estimated Net Worth of Stuart Poulton is at least $303 Tisíc dollars as of 30 July 2024. Stuart Poulton owns over 2,883 units of Karyopharm Therapeutics Inc stock worth over $241,705 and over the last 2 years Stuart sold KPTI stock worth over $60,901.
Stuart has made over 5 trades of the Karyopharm Therapeutics Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Stuart sold 2,883 units of KPTI stock worth $3,056 on 30 July 2024.
The largest trade Stuart's ever made was selling 22,466 units of Karyopharm Therapeutics Inc stock on 29 February 2024 worth over $26,510. On average, Stuart trades about 4,989 units every 66 days since 2023. As of 30 July 2024 Stuart still owns at least 326,628 units of Karyopharm Therapeutics Inc stock.
You can see the complete history of Stuart Poulton stock trades at the bottom of the page.
Stuart's mailing address filed with the SEC is C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, NEWTON, MA, 02459.
Over the last 11 years, insiders at Karyopharm Therapeutics Inc have traded over $149,223,596 worth of Karyopharm Therapeutics Inc stock and bought 562,763 units worth $10,312,371 . The most active insiders traders include Deepika Pakianathan, Ltd Czernik Marcin Hadjimic... a Mikael Dolsten. On average, Karyopharm Therapeutics Inc executives and independent directors trade stock every 12 days with the average trade being worth of $26,350. The most recent stock trade was executed by Michael Mano on 4 September 2024, trading 3,971 units of KPTI stock currently worth $2,859.
karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com
Karyopharm Therapeutics Inc executives and other stock owners filed with the SEC include: